Last reviewed · How we verify
MTZ (mtz)
At a glance
| Generic name | mtz |
|---|---|
| Sponsor | Pfizer Inc. |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
- nausea
- Vomiting
- Pyrexia
- Anaemia
- Nausea
- Dizziness
- Alanine aminotransferase increased
- Diarrhoea
- Hypokalaemia
- headache
- Aspartate aminotransferase increased
- Hepatic function abnormal
Key clinical trials
- Repurposing Mirtazapine in Rett Syndrome (PHASE2)
- MRD-positive AML Clinical Study (NA)
- Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children (NA)
- Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole (PHASE4)
- Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia (PHASE3)
- A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. (PHASE3)
- High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ) (PHASE2)
- Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |